Outset Medical, Inc. financial data

Symbol
OM on Nasdaq
Location
San Jose, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 738% % 16%
Quick Ratio 140% % 7%
Debt-to-equity 91% % -78%
Return On Equity -55% % 75%
Return On Assets -29% % 31%
Operating Margin -56% % 44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,311,626 shares
Common Stock, Shares, Outstanding 18,169,000 shares 415%
Entity Public Float $334,700,000 USD 69%
Common Stock, Value, Issued $18,000 USD 350%
Weighted Average Number of Shares Outstanding, Basic 15,211 shares 339%
Weighted Average Number of Shares Outstanding, Diluted 15,211 shares 339%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $119,476,000 USD 5.1%
Research and Development Expense $21,235,000 USD -45%
Selling and Marketing Expense $54,361,000 USD -22%
General and Administrative Expense $37,864,000 USD -13%
Operating Income (Loss) $66,706,000 USD 41%
Nonoperating Income (Expense) $7,408,000 USD -24%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $80,935,000 USD 37%
Income Tax Expense (Benefit) $718,000 USD 46%
Net Income (Loss) Attributable to Parent $81,653,000 USD 36%
Earnings Per Share, Basic -5.37 USD/shares 85%
Earnings Per Share, Diluted -5.37 USD/shares 85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $35,006,000 USD -72%
Accounts Receivable, after Allowance for Credit Loss, Current $28,329,000 USD -20%
Inventory, Net $47,609,000 USD -20%
Assets, Current $250,883,000 USD -2.8%
Property, Plant and Equipment, Net $4,670,000 USD -43%
Operating Lease, Right-of-Use Asset $4,797,000 USD 22%
Other Assets, Noncurrent $317,000 USD -85%
Assets $264,496,000 USD -4.1%
Accounts Payable, Current $554,000 USD -86%
Contract with Customer, Liability, Current $13,795,000 USD 8.2%
Liabilities, Current $37,630,000 USD -17%
Contract with Customer, Liability, Noncurrent $406,000 USD -52%
Operating Lease, Liability, Noncurrent $3,271,000 USD 22%
Liabilities $137,544,000 USD -45%
Accumulated Other Comprehensive Income (Loss), Net of Tax $172,000 USD 310%
Retained Earnings (Accumulated Deficit) $1,171,376,000 USD -7.5%
Stockholders' Equity Attributable to Parent $126,952,000 USD 373%
Liabilities and Equity $264,496,000 USD -4.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,663,000 USD 44%
Net Cash Provided by (Used in) Financing Activities $55,656,000 USD -19%
Net Cash Provided by (Used in) Investing Activities $78,079,000 USD -32%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 18,169,000 shares 415%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $48,086,000 USD -32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36,616,000 USD -7.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities $7,364,000 USD 50%
Deferred Tax Assets, Valuation Allowance $259,423,000 USD 6.2%
Deferred Tax Assets, Gross $260,582,000 USD 6.3%
Operating Lease, Liability $5,010,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $123,000 USD -65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $81,523,000 USD 36%
Lessee, Operating Lease, Liability, to be Paid $6,190,000 USD 25%
Property, Plant and Equipment, Gross $29,569,000 USD 1.4%
Operating Lease, Liability, Current $1,739,000 USD -3.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,503,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,058,000 USD -2.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.104 pure 18%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,180,000 USD 147%
Lessee, Operating Lease, Liability, to be Paid, Year Three $729,000 USD -14%
Deferred Tax Assets, Operating Loss Carryforwards $201,253,000 USD 11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $4,971,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Four $696,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,294,000 USD -11%
Deferred Tax Assets, Net of Valuation Allowance $1,159,000 USD 17%
Share-based Payment Arrangement, Expense $15,616,000 USD -47%
Interest Expense $13,952,000 USD -42%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%